WASHINGTON, July 15, 2014 /PRNewswire-USNewswire/ -- The Reagan-Udall Foundation for the FDA (RUF), an independent not-for-profit organization created by Congress for the purpose of advancing regulatory science critical to helping the U.S. Food and Drug Administration accomplish its mission, today announced that Mark C. Rogers, M.D., M.B.A., has been elected as Chairman of the RUF Board of Directors.
"It's an honor to welcome a physician, scientist, educator and executive as distinguished as Dr. Rogers to govern our Board," said Ellen V. Sigal, Ph.D., RUF Board Vice Chairman and Interim Board Chairman during the search. "Dr. Rogers brings with him decades of outstanding leadership in several fields of medicine and business. His experience and guidance will help to strengthen the Foundation's contribution to regulatory science." Dr. Rogers succeeds Mark McClellan, M.D., Ph.D., the Board's founding Chairman, who continues to support the Foundation as a Board member leading the Innovation in Medical Evidence Development and Surveillance (IMEDS) program.
"It's a great privilege to be appointed Chair of this unique collaboration that has already contributed so much to advancing public health in just a few years," said Dr. Rogers. "I have great confidence that we'll continue to make important strides in accelerating regulatory science and ensuring FDA-regulated products that reach consumers continue to meet the highest standards of safety, efficacy and quality."
Following Dr. Rogers' appointment in 1977 as the first Director of the Pediatric Intensive Care Unit at The Johns Hopkins Hospital, he went on to be appointed Professor and Chair of the Department of Anesthesiology and Critical Care Medicine, then Associate Dean. He received his M.B.A. from the Wharton School of the University of Pennsylvania and, among other publications, authored what is now the international standard textbook in pediatric intensive care. Dr. Rogers has held several senior, pioneering leadership and foundational roles in biotechnology and biopharmaceutical companies and is involved in a number of public service activities.
The Reagan-Udall Foundation for the FDA is an independent 501(c)(3) not-for-profit organization created by Congress to advance the mission of the FDA by advancing regulatory science and research. With the ultimate goal of improving public health, the Foundation provides a unique opportunity to bring all parties to the table (FDA, patient groups, academia, other government entities and industry) to work together in a transparent way to create exciting new regulatory science.
|SOURCE Reagan-Udall Foundation for the FDA|
Copyright©2014 PR Newswire.
All rights reserved